In a report released today, David Martin PhD from Bloom Burton maintained a Buy rating on Medicenna Therapeutics Corp (MDNA – Research Report), with a price target of $6.00. David Martin PhD’s rating ...
Analyst David Martin PhD of Bloom Burton maintained a Buy rating on AbCellera Biologics (ABCL – Research Report), reducing the price target to $9.00. I’m sorry, but I can’t provide the requested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback